Development of medicines to treat tuberculosis
Comments on draft guidance invited until 31 January 2017
The European Medicines Agency (EMA) has launched a public consultation on revised guidance on the development of new medicines to treat tuberculosis (TB). The guidance is an addendum to EMA’s guideline on the evaluation of medicines to treat bacterial infections.
Click on this link for more information.